Amazon, GoodRx target US prescription subscribers as health insurance coverage slips

Amazon.com and GoodRx are capitalizing on Americans' struggles with soaring prescription drug costs and declining health insurance choices by offering flat fee subscription plans. Amazon's RxPass starts at $5 per month and grants free access to select generic drugs, while GoodRx's Companion program, launched in May, costs between $5 and $14.99 per month and includes discounts on telehealth, vision, dental and lab services.

Analysts suggest that these monthly fee-based services can help consumers save money even when they have health insurance. As health insurance premiums and out-of-pocket costs have risen, millions of Americans have dropped individual plans under the Affordable Care Act in 2026. Employers who sponsor most private insurance plans will see their costs rise up to 11% in 2027.

Amazon's RxPass has attracted nearly three times as many customers since its launch in 2023, with over 70% purchasing three or more medications. GoodRx reported a 39% increase in subscription revenue to $28.5 million in the second quarter compared to the previous year. While it's unclear how many Americans are enrolled in prescription drug subscription plans, GoodRx CEO Wendy Barnes sees these plans as a complement to insurance.

Amazon's Love noted that the plans attract both insured and uninsured consumers, with many opting to pay with cash. The plans can also lead customers to other products sold by the companies on their websites. Amazon's Love added that the plans are "simple and predictable," an important factor for consumers navigating complicated coverage changes.